NCT05694182

Brief Summary

This study is conducted to evaluate the safety and effectiveness of an oral superfruits supplement for skin brightening and wrinkle reduction. Superfruits are reported to have high bioactive compounds with beneficial effects on human health. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 2, week 6 and week 12. The participants will consume the supplement for 6 weeks and at week 12, final skin assessment will be conducted. The main questions this study aims to answer are:

  1. 1.The skin brightening effect of the oral superfruits supplement.
  2. 2.The effect of the oral superfruits supplement on wrinkle reduction.
  3. 3.To observe any adverse effect occurrence with the consumption of the oral superfruits supplement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 11, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

7 months

First QC Date

January 11, 2023

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in skin tone from baseline and at week 2, week 6 and week 12 after consumption of the superfruits supplement

    Skin tone will be assessed using JANUS III skin analyzer

    Baseline, week 2, week 6 and week 12

  • Changes in skin wrinkles from baseline and at week 2, week 6 and week 12 after consumption of the superfruits supplement

    Skin wrinkles will be assessed using JANUS III skin analyzer and Wrinkle Severity Rating Scale (WSRS). For WSRS, dermatologists will evaluate participants' wrinkles based on 5-point photonumeric rating scale that will objectively evaluate the severity of crow's feet at rest (static) and with a smiling expression (dynamic). The scale scores are 0 for no wrinkles, 1 for very fine wrinkles, 2 for fine wrinkles, 3 for moderate wrinkles, and 4 for severe wrinkles.

    Baseline, week 2, week 6 and week 12

  • Adverse effect after consumption of the superfruits supplement

    Based on adverse effect occurrence on participants that occur during study period (12 weeks)

    Week 12

Study Arms (1)

Oral superfruits supplement

EXPERIMENTAL

Participants will consume oral superfruits supplement once daily for 6 weeks.

Other: Other: Oral superfruits supplement

Interventions

The supplement contain superfruits that are beneficial for human health

Oral superfruits supplement

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Malaysian citizen
  • Male and female (age 20-60 years old)

You may not qualify if:

  • Participant who taking any dietary supplements for the past 4 weeks which can affect the study results
  • Participant who are on contraceptive pills for the past 3 months
  • Participant who undergo cosmetics treatments such as botox, filler and laser and light treatment within the last 3 months
  • Pregnant or plans to get pregnant and breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Petaling Jaya, Selangor, 47810, Malaysia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2023

First Posted

January 23, 2023

Study Start

December 1, 2022

Primary Completion

June 30, 2023

Study Completion

December 1, 2023

Last Updated

March 28, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations